Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03417557 · ClinicalTrials.gov registry record · NA

Clinical Validation Study of Comfilcon A Multifocal Toric Contact Lenses

A NA study of Presbyopia, sponsored by CooperVision.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT03417557 is a NA study of Presbyopia that has completed, run by CooperVision. The registered enrollment target is 20 participants, below the 270-participant average among 38 other Presbyopia trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03417557, a NA study of Presbyopia, has completed, sponsored by CooperVision.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This is a study to evaluate the clinical performance and subjective acceptance of an investigational contact lens (test), compared to a marketed lens (control) in an in-office setting.

Conditions Studied

Interventions

  • DEVICE Comfilcon A lens (test)
  • DEVICE Omafilcon B lens (control)

Study Locations (1)

Indiana

  • Clinical Optics Research Lab (CORL) Indiana University School of Optometry, Indiana University - Bloomington

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2018-01-12
Est. Completion 2018-04-03
Phase NA

Sponsor

CooperVision

64 total trials

What the Registry Record Tells You About NCT03417557

The ClinicalTrials.gov registry entry for NCT03417557 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 270-participant average among 38 other Presbyopia trials with a reported enrollment target (93% lower). The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Presbyopia appearing as the primary indexed condition, and to 2 interventions - of which Comfilcon A lens (test) is the first listed.

NCT03417557 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT03417557 about?

NCT03417557 is a clinical study titled "Clinical Validation Study of Comfilcon A Multifocal Toric Contact Lenses". This is a study to evaluate the clinical performance and subjective acceptance of an investigational contact lens (test), compared to a marketed lens (control) in an in-office setting.

What is the current status of trial NCT03417557?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-01-12. Estimated completion is 2018-04-03.

What conditions does trial NCT03417557 study?

This clinical trial studies the following conditions: Presbyopia.

What interventions are being tested in trial NCT03417557?

The interventions under investigation include: Comfilcon A lens (test) (DEVICE), Omafilcon B lens (control) (DEVICE).

Who is sponsoring clinical trial NCT03417557?

This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03417557 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Presbyopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.